1. Paediatric Oncology at the Crossroads: A Call for Change

   • Klaus Rose

   Editorial 07 October 2020 Pages: 297 - 300

2. Developing Medical Affairs Leaders Who Create the Future

   • Alexander Bedenkov
   • Viraj Rajadhyaksha
   • Sarah Odell

   Current Opinion Open access 19 September 2020 Pages: 301 - 307

   

3. Patient Experience Information: Streamlining and Harmonizing the Collection of Patient Preference and Patient-Reported Outcomes Data

   • Matthew Reaney
   • Ana Maria Rodriguez

   Current Opinion 06 November 2020 Pages: 309 - 314

4. Proposal of Standard for Medical Science Liaison (MSL) Profession in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMed)

   • Michiko Tomiyasu
   • Kunihiko Hayashi
   • Koji Iwasaki

   Current Opinion 08 October 2020 Pages: 315 - 326

   

5. Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil

   • Marcelo Vogler
   • Heloísa Ricci Conesa
   • Yannie Silveira Gonçalves

   Leading Article Open access 15 September 2020 Pages: 327 - 334

   

6. A Comprehensive Methodology to Systematically Identify Drug Hypersensitivity and Anaphylactic Reactions in Clinical Trial Databases

   • Hugo Xavier
   • Indira Hara
   • Claire Morgan

   Original Research Article 25 September 2020 Pages: 335 - 345

   

7. Forum

   Update 29 September 2020 Pages: 347 - 355

8. Major Pharmaceutical Conferences and Courses

   Update 06 October 2020 Pages: 357 - 358

9. Comment on: “Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered”

   • Carlos E. Matos dos Santos
   • Daniel Junqueira Dorta
   • Danielle Palma de Oliveira

   Letter to the Editor 20 October 2020 Pages: 359 - 360

10. Authors’ Reply to Santos et al.: “Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered”

    • Kristine Svinning Valeur
    • Helle Holst
    • Karel Allegaert

    Letter to the editor 20 October 2020 Pages: 361 - 362